Clinical Trials Directory

Trials / Unknown

UnknownNCT05148728

Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors

Prospective Randomized Trial in Low Grade Bladder Tumors: Active Surveillance vs Endoscopic Fulguration.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
120 (estimated)
Sponsor
Vall Hebron Insitut Recerca · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Biological behabiour of low grade bladder cancer tumors is well known. They have a very high rate of recurrences during their follow up but very low (less than 1%) risk of progression. Until now, the gold standard of any bladder recurrence for this patients is performing an immediate transurethral ressection of the tumor. This surgery has risk of complications and, due to the low risk of these subgroup of tumors, sometimes it becomes an overtreatment for the patients. This is the reason why new conservative or less invasive surgeries are proposed to follow up and treat these patients.

Conditions

Interventions

TypeNameDescription
PROCEDUREEndoscopic fulgurationalready included. WE will use Storz monopolar device for fulguration

Timeline

Start date
2021-12-15
Primary completion
2023-12-15
Completion
2024-03-15
First posted
2021-12-08
Last updated
2021-12-08

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05148728. Inclusion in this directory is not an endorsement.

Active Surveillance vs in Office Fulguration for Low Grade Bladder Cancer Tumors (NCT05148728) · Clinical Trials Directory